{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:07Z","timestamp":1707524647670},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,8]]},"DOI":"10.7759\/cureus.28937","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T14:41:16Z","timestamp":1662648076000},"source":"Crossref","is-referenced-by-count":0,"title":["Five-Year Remission of Hidradenitis Suppurativa Following the Removal of a Levonorgestrel Intrauterine Device and Disease Overview for Obstetrics and Gynecology Providers"],"prefix":"10.7759","author":[{"given":"Meredith H","family":"Hengy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Cevigney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Komalpreet","family":"Tur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlee","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Ivey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.090","article-title":"Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis","volume":"82","author":"Goldburg SR","year":"2020","unstructured":"Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2020, 82:1045-58. 10.1016\/j.jaad.2019.08.090","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis suppurativa: advances in diagnosis and treatment","volume":"318","author":"Saunte DM","year":"2017","unstructured":"Saunte DM, Jemec GB. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA. 2017, 318:2019-32. 10.1001\/jama.2017.16691","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1556\/650.2019.31319","article-title":"[Gynecological aspects of hidradenitis suppurativa]","volume":"160","author":"Kiss N","year":"2019","unstructured":"Kiss N, Pl\u00e1z\u00e1r D, L\u0151rincz K, B\u00e1nv\u00f6lgyi A, Valent S, Wikonk\u00e1l N. [Gynecological aspects of hidradenitis suppurativa]. Orv Hetil. 2019, 160:291-9. 10.1556\/650.2019.31319","journal-title":"Orv Hetil"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12788\/j.sder.2017.017","article-title":"Pathophysiology of hidradenitis suppurativa","volume":"36","author":"Hoffman LK","year":"2017","unstructured":"Hoffman LK, Ghias MH, Lowes MA. Pathophysiology of hidradenitis suppurativa. Semin Cutan Med Surg. 2017, 36:47-54. 10.12788\/j.sder.2017.017","journal-title":"Semin Cutan Med Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.08.047","article-title":"Pathogenesis and pharmacotherapy of hidradenitis suppurativa","volume":"672","author":"Nazary M","year":"2011","unstructured":"Nazary M, van der Zee HH, Prens EP, Folkerts G, Boer J. Pathogenesis and pharmacotherapy of hidradenitis suppurativa. Eur J Pharmacol. 2011, 672:1-8. 10.1016\/j.ejphar.2011.08.047","journal-title":"Eur J Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12362","article-title":"A case series of 20 women with hidradenitis suppurativa treated with spironolactone","volume":"56","author":"Lee A","year":"2015","unstructured":"Lee A, Fischer G. A case series of 20 women with hidradenitis suppurativa treated with spironolactone. Australas J Dermatol. 2015, 56:192-6. 10.1111\/ajd.12362","journal-title":"Australas J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/09546630510031403","article-title":"Hidradenitis suppurativa treated with finasteride","volume":"16","author":"Joseph MA","year":"2005","unstructured":"Joseph MA, Jayaseelan E, Ganapathi B, Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatolog Treat. 2005, 16:75-8. 10.1080\/09546630510031403","journal-title":"J Dermatolog Treat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00557-5","article-title":"Hormonal contraceptives and dermatology","volume":"22","author":"Williams NM","year":"2021","unstructured":"Williams NM, Randolph M, Rajabi-Estarabadi A, Keri J, Tosti A. Hormonal contraceptives and dermatology. Am J Clin Dermatol. 2021, 22:69-80. 10.1007\/s40257-020-00557-5","journal-title":"Am J Clin Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2020.09.002","article-title":"Characterizing perimenstrual flares of hidradenitis suppurativa","volume":"6","author":"Collier EK","year":"2020","unstructured":"Collier EK, Price KN, Grogan TR, Naik HB, Shi VY, Hsiao JL. Characterizing perimenstrual flares of hidradenitis suppurativa. Int J Womens Dermatol. 2020, 6:372-6. 10.1016\/j.ijwd.2020.09.002","journal-title":"Int J Womens Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a\u00a0publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part II: topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan A","year":"2019","unstructured":"Alikhan A, Sayed C, Alavi A, et al.. North American clinical management guidelines for hidradenitis suppurativa: a\u00a0publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part II: topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019, 81:91-101. 10.1016\/j.jaad.2019.02.068","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5070\/D35vw402nf","article-title":"Hidradenitis suppurativa: a practical review of possible medical treatments based on over 350 hidradenitis patients","volume":"19","author":"Scheinfeld N","year":"2013","unstructured":"Scheinfeld N. Hidradenitis suppurativa: a practical review of possible medical treatments based on over 350 hidradenitis patients. Dermatol Online J. 2013, 19:1. 10.5070\/D35vw402nf","journal-title":"Dermatol Online J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17900","article-title":"KITTEN following CAT on the long-term use of rifampicin in hidradenitis suppurativa and effectiveness of oral contraceptives","volume":"181","author":"Yazdanyar S","year":"2019","unstructured":"Yazdanyar S, Jemec GB. KITTEN following CAT on the long-term use of rifampicin in hidradenitis suppurativa and effectiveness of oral contraceptives. Br J Dermatol. 2019, 181:225-6. 10.1111\/bjd.17900","journal-title":"Br J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.11337.1","article-title":"Hidradenitis suppurativa: an update on connecting the tracts","volume":"6","author":"Smith MK","year":"2017","unstructured":"Smith MK, Nicholson CL, Parks-Miller A, Hamzavi IH. Hidradenitis suppurativa: an update on connecting the tracts. F1000Res. 2017, 6:1272. 10.12688\/f1000research.11337.1","journal-title":"F1000Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/101953-five-year-remission-of-hidradenitis-suppurativa-following-the-removal-of-a-levonorgestrel-intrauterine-device-and-disease-overview-for-obstetrics-and-gynecology-providers","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:50:38Z","timestamp":1707508238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/101953-five-year-remission-of-hidradenitis-suppurativa-following-the-removal-of-a-levonorgestrel-intrauterine-device-and-disease-overview-for-obstetrics-and-gynecology-providers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.28937","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,8]]}}}